0
Protalix BioTherapeutics, Inc. Banner Image

Protalix BioTherapeutics, Inc.

  • Ticker PLX
    Exchange AMEX More
  • Industry Biotechnology More
  • Sector Healthcare More
Protalix BioTherapeutics, Inc. Logo Image
  • 201-500 Employees
  • Based in Karmiel, Israel
Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.
REPORT RATINGS
4.8 / 5.0 (264)

Protalix BioTherapeutics, Inc. reports have an aggregate usefulness score of 4.8 based on 264 reviews.

Protalix BioTherapeutics, Inc.

Most Recent Annual Report

Protalix BioTherapeutics, Inc.
MOST RECENT 2022 Annual Report and Form 10K

Protalix BioTherapeutics, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Protalix BioTherapeutics, Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!